Although this study establishes the NLRP3 inflammasome as a central player in the pathology of MDS, further research is needed to confirm the precise in vivo role of the NLRP3 inflammasome in the development and progression of MDS. Here, NLRP3 is linked to myelodysplastic syndrome.